ATSENA Trademark

Trademark Overview

On Monday, April 6, 2020, a trademark application was filed for ATSENA with the United States Patent and Trademark Office. The USPTO has given the ATSENA trademark a serial number of 88860854. The federal status of this trademark filing is REGISTERED as of Tuesday, February 27, 2024. This trademark is owned by Atsena Therapeutics, Inc.. The ATSENA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Gene therapy pharmaceutical preparations, namely, adeno-associated virus gene therapies for treatment of ocular disorders

Scientific research in the field of gene therapies and genetic diseases; scientific research in the field of adeno-associated viruses; development of new technologies for others related to adeno-associated viruses; development of new products for others, namely, development of gene therapy products and pharmaceutical preparations related to adeno-associated viruses
atsena

General Information

Serial Number88860854
Word MarkATSENA
Filing DateMonday, April 6, 2020
Status700 - REGISTERED
Status DateTuesday, February 27, 2024
Registration Number7316506
Registration DateTuesday, February 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2020

Trademark Statements

Goods and ServicesGene therapy pharmaceutical preparations, namely, adeno-associated virus gene therapies for treatment of ocular disorders
Translation of Words in MarkThe wording "ATSENA" has no meaning in a foreign language.
Goods and ServicesScientific research in the field of gene therapies and genetic diseases; scientific research in the field of adeno-associated viruses; development of new technologies for others related to adeno-associated viruses; development of new products for others, namely, development of gene therapy products and pharmaceutical preparations related to adeno-associated viruses

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 13, 2020
Primary Code005
First Use Anywhere DateThursday, August 31, 2023
First Use In Commerce DateThursday, August 31, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 13, 2020
Primary Code042
First Use Anywhere DateMonday, January 9, 2023
First Use In Commerce DateMonday, January 9, 2023

Trademark Owner History

Party NameAtsena Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27709
Party NameAtsena Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27709
Party NameAtsena Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27701

Trademark Events

Event DateEvent Description
Thursday, April 9, 2020NEW APPLICATION ENTERED
Monday, April 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 24, 2020ASSIGNED TO EXAMINER
Wednesday, July 1, 2020NON-FINAL ACTION WRITTEN
Wednesday, July 1, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 19, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 19, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, August 19, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 19, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, August 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 22, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, May 13, 2021SOU EXTENSION 1 FILED
Thursday, May 13, 2021SOU EXTENSION 1 GRANTED
Saturday, May 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 16, 2021SOU EXTENSION 2 FILED
Tuesday, November 16, 2021SOU EXTENSION 2 GRANTED
Thursday, November 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 11, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 11, 2022SOU EXTENSION 3 FILED
Wednesday, May 11, 2022SOU EXTENSION 3 GRANTED
Friday, May 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022SOU EXTENSION 4 FILED
Tuesday, November 15, 2022SOU EXTENSION 4 GRANTED
Thursday, November 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023SOU EXTENSION 5 FILED
Friday, May 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 19, 2023SOU EXTENSION 5 GRANTED
Saturday, May 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 17, 2023USE AMENDMENT FILED
Friday, November 17, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 28, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 28, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, November 28, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 19, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, January 20, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 27, 2024REGISTERED-PRINCIPAL REGISTER

Related Keywords

atsena adeno associated gene viruses development scientific field research others therapies